Shukra Pharma: FY26 Results Declared; Dividend ₹0.01 Recommended

Shukra Pharmaceuticals Ltd declared its financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the standalone and consolidated audited financial results. A final dividend of ₹0.01 (1%) per equity share has been recommended, subject to shareholder approval. Additionally, the board approved the allotment of 17,35,000 equity shares to warrant holders Dakshesh Shah and Parshva Texchem India Private Limited upon conversion of warrants, increasing the paid-up equity capital to ₹43,96,14,440.